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a  b  s  t  r  a  c  t
RFamide-related  peptide  3  (RFRP3)  has been  implicated  in  regulating  reproduction  and
growth.  This regulation  appears  to  be  dependent  upon  sex,  species,  physiological  status,
and developmental  stage.  The  objective  of  the  present  study  was  to  evaluate  the  effects  of
RFRP3  on  circulating  concentrations  of  luteinizing  hormone  (LH)  and  growth  hormone  (GH)
in mature  boars.  The  hypothesis  was  RFRP3  would  reduce  circulating  concentrations  of  LH
and  increase  concentrations  of GH.  Meishan  boars  (716.6  ± 2.8 days  of age;  125.0  ± 12.4  kg
BW) were randomly  assigned  to treatment:  saline  (n = 4) or RFRP3  (8.5  mg;  n  =  5).  Plasma
was collected  at 15-min  intervals  during  3  periods:  pre-treatment,  treatment,  and  post-
treatment.  During  the  treatment  period,  saline  or RFRP3  were  administered  at 15-min
intervals.  Treatment  was administered  as a loading  dose  of  5  mg  RFRP3,  followed  by seven
repeated  injections  of  0.5  mg  RFRP3.  Pulsatile  secretion  of LH  and  GH  were  not  affected  by
saline  treatment.  Mean  concentrations  of  LH  in  RFRP3-treated  boars  were  greater  (P <  0.01)
in  the  pre-treatment  period  than  in  the  treatment  and  post-treatment  periods;  however,
the  individual  response  to  RFRP3  challenge  was  varied.  RFRP3  suppressed  (P <  0.05)  mean
concentrations  of  GH during  the  treatment  period.  It  is  concluded  that  RFRP3  can  act
to suppress  LH  secretion  in  some  boars,  but the  minimal  and  varied  response  between
animals  does  not  strongly  support  the idea  that  RFRP3  is a potent  hypohysiotropic  hor-
mone  in the  pig.  Results  indicate  that  RFRP3  may  function  in  regulating  the  growth  axis  of
swine.
Published  by  Elsevier  B.V.
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recommendation or endorsement by the U.S. Department of Agriculture.
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1. Introduction
Secretion of gonadotropin-releasing hormone (GnRH)
and growth hormone-releasing hormone (GHRH) orches-
trate the reproductive and growth axes, respectively.
However, hypothalamic neuropeptides that function as
central regulators of GnRH and GHRH are not well under-
stood in the boar. A single member of the RFamide family
of peptides, RFamide-related peptide 3 (RFRP3), has been
implicated in regulating GnRH and GHRH neuronal expres-
sion and function (Ancel et al., 2012; Ducret et al., 2009;
Johnson and Fraley, 2008) as well as secretion of luteiniz-
ing hormone (LH; Ancel et al., 2012; Johnson et al., 2007;
Johnson and Fraley, 2008; Kadokawa et al., 2009) and
growth hormone (GH; Johnson et al., 2007; Johnson and
Fraley, 2008) in male mammals.
Responsiveness of the reproductive neuroendocrine
axis to RFRP3 appears to be dependent upon sex, species,
physiological status, and developmental stage. Recent evi-
dence in the seasonally reproductive hamster suggests that
the function of RFRP3 is sexually dimorphic. In the mature
intact male hamster, central infusion of RFRP3 increased
LH, FSH, testosterone, and GnRH neuronal c-Fos expres-
sion whereas peripheral injection of RFRP3 failed to alter
LH secretion (Ancel et al., 2012). This contradicts findings
from female hamsters, in which both central and peripheral
treatment with RFRP3 inhibited LH secretion (Kriegsfeld
et al., 2006). In non-seasonal species, such as rats or cat-
tle, peripheral infusion of RFRP3 inhibited the gonadotropic
axis of males (Johnson and Fraley, 2008; Kadokawa et al.,
2009). The RFRP mRNA in the dorsomedial nucleus of the
hypothalamus of mice decreased with maturity (Poling
et al., 2012). Consequently, RFRP3 has been proposed to
be involved in the onset of puberty; however, infusion
of RFRP3 was unable to prevent the onset of puberty in
the intact male rat (Johnson and Fraley, 2008). In spite of
decreased expression during adulthood, RFRP3 suppressed
concentrations of LH and sexual behavior and increased
concentrations of GH and feed intake in the mature male
rat (Johnson et al., 2007).
The role of RFRP3 in the boar is unknown. Therefore, the
objective of the present study was to evaluate the effects
of RFRP3 on circulating concentrations of LH and GH in
mature, intact Chinese Meishan boars. It was hypothesized
that RFRP3 would reduce circulating concentrations of LH,
while increasing concentrations of GH.
2. Materials and methods
2.1. Experimental design
This study was conducted using standard production
and experimental practices that were in accordance with
the Guide for the Care and Use of Agricultural Animals
in Agricultural Research and Teaching (FASS, 2010) and
were approved by the U.S. Meat Animal Research Center.
Mature, Chinese Meishan boars (716.6 ± 2.8 days of age;
125.0 ± 12.4 kg BW)  were fitted with indwelling jugular
catheters (Ford and Maurer, 1978) at least 1 week prior
to treatment. Boars were individually housed in 2 × 3 m
pens with ad libitum access to water and were offered a
fortified corn soybean-meal diet that met  or exceeded
nutrient requirements (NRC, 1998). Boars were assigned
randomly to either saline (n = 4) or RFRP3 (n = 5) treat-
ment. Blood was  collected at 15-min intervals over three
periods: pre-treatment (minute 0–75), treatment (minute
75–180), and post-treatment (minute 180–285). During
the treatment period, 0.9% saline and RFRP3 (Val-Pro-Asn-
Leu-Pro-Gln-Arg-Phe-NH2; GenScript Inc., Piscataway, NJ)
suspended in 0.9% saline were administered at 15-min
intervals immediately following blood collection. A load-
ing dose of 5 mg  of RFRP3 followed by repeated injections of
0.5 mg  of RFRP3 every 15 min  for 105 min  resulted in a total
infusion of 8.5 mg  (approximately 0.07 mg  RFRP3/kg BW)
of peptide per animal. The dose was based from research
with gilts (Heidorn et al., 2010). Blood was collected in
heparinized syringes immediately before each 15-minute
treatment infusion.
2.2. Hormone analyses
Plasma was harvested (2,000 × g for 20 min  at 4 ◦C) and
stored at −20 ◦C. Concentrations of LH and GH in plasma
were determined by RIA as described previously (Kesner
et al., 1987; Lents et al., 2008). The reference standards
for LH (AFP-10506A) and GH (AFP-10864B) were provided
by Dr. A.F. Parlow (Scientific Director of the NIH, NIDDK,
National Hormone and Peptide Program). Pools of porcine
plasma with LH concentrations that ranged from 0.22 to
3.75 ng/ml were included in each assay. The intra- and
inter-assay CV were, 9.3 and 7.9%, respectively. Sensitiv-
ity of the LH assay (defined as 90% of Bo) was  0.1 ng/ml.
Plasma concentrations of GH were determined in a single
assay with an intra-assay CV of 12.0%. Sensitivity of the GH
assay (90% of Bo) was  0.18 ng/ml. Plasma concentrations
of testosterone were determined in duplicate according to
Ford et al. (2001). The minimum sensitivity of the assay was
50 pg/ml and intra-assay CV was 13%.
2.3. Pulse analyses
Characterizations of LH pulses were adapted from pre-
viously described factors (Goodman et al., 2012): (1) the
peak occurred within two  samples of the previous nadir,
(2) pulse amplitude exceeded assay sensitivity, and (3)
the peak was  two standard deviations above the preced-
ing nadir (nadir concentrations within animal). Luteinizing
hormone pulse frequency was quantified across all periods.
Inter-pulse interval was  quantified as the interval of time
between pulse peaks from the pre-treatment to the post-
treatment period and means calculated within animal for
statistical analysis. Pulse amplitude was calculated across
all period as the difference between the peak pulse con-
centration and the preceding nadir and means calculated
within animal. One exception was  when the pulse occurred
within two samples of initiation of sampling, in these cases
the following nadir was  utilized.
2.4. Statistical analyses
Main effects of treatment on concentrations of LH
and GH in plasma were determined using the MIXED
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Fig. 1. Plasma concentrations of luteinizing hormone during the pre-treatment (minute 0–75), treatment (minute 75–180), and post-treatment (minute
180–285) periods in representative boars for each treatment group. Boars were treated with either saline (dashed line) or RFRP3 (8.5 mg; solid line)
during  the treatment period. The large arrow indicates administration of the loading dose (5 mg RFRP3/boar), while the small arrows indicate the repeated
injections (0.5 mg  RFRP3/boar).
procedure of SAS (SAS Institute Inc., Cary, NC). The model
included treatment, period, and treatment × period inter-
action. Compound symmetry was used to model the
covariance structure for the repeated measure. Quantifi-
cation of differences in mean pulse frequency between
treatments was analyzed using the Kruskal–Wallis test
for nonparametric, noncontinuous data. Mean inter-pulse
interval and pulse amplitude were analyzed by the GLM
procedure of SAS with treatment included as the source of
variation. Data are reported as Least Squares means ± SEM,
unless stated otherwise. Effects were considered signifi-
cant when P ≤ 0.05.
3. Results
3.1. Effects of RFRP3 on secretion of LH
Individual profiles of LH in plasma of representative
boars for each treatment group are presented in Fig. 1. Ani-
mal  to animal variation in the secretory pattern of LH can
be observed. There was a treatment × period interaction
(P < 0.04) for mean concentrations of LH (Fig. 2). Mean con-
centrations of LH in plasma did not differ (P > 0.52) between
periods for saline-treated animals; however, mean concen-
trations of LH were greater (P < 0.01) in the pre-treatment
period compared with treatment and post-treatment
periods in RFRP3-treated boars. There was no difference
between treatments in number of LH pulses (4.3 ± 1.3 com-
pared with 4.4 ± 0.5 pulses; P = 0.90), LH pulse amplitude
(0.38 ± 0.16 compared with 0.37 ± 0.08; P = 0.95), or inter-
pulse interval (P = 0.27) between saline- and RFRP3-treated
boars, respectively, over the entire sampling time. Plasma
concentrations of testosterone averaged 6.2 ± 2.0 ng/ml,
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Fig. 2. Least squares means (±SEM) for plasma concentrations of luteiniz-
ing hormone during the pre-treatment (minute 0–75), treatment (minute
75–180), and post-treatment (minute 180–285) periods. Boars were
treated with either saline (n = 4; no fill) or 8.5 mg RFRP3 (n = 5; solid fill)
during the treatment period. Treatment × Period, P < 0.04. a,bWithin treat-
ment, means are different (P < 0.01).
and were not different (P > 0.30) between saline and RFRP3-
treated boars.
3.2. Effects of RFRP3 on secretion of GH
Individual profiles of GH in plasma of representative
boars for each treatment group are presented in Fig. 3.
There was  a treatment × period interaction (P < 0.01) for
mean concentrations of GH (Fig. 4). Mean concentrations
of GH in RFRP3-treated boars were reduced (P < 0.04)
during the treatment period compared with pre- and post-
treatment periods. Mean concentrations of GH did not
differ (P > 0.39) between saline- and RFRP3-treated boars
during the pre- and post-treatment period.
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Fig. 3. Plasma concentrations of growth hormone during the pre-treatment (minute 0–75), treatment (minute 75–180), and post-treatment (minute
180–285) periods in representative boars for each treatment group. Boars were treated with either saline (dashed line) or RFRP3 (8.5 mg;  solid line)
during  the treatment period. The large arrow indicates administration of the loading dose (5 mg RFRP3/boar), while the small arrows indicate the repeated
injections (0.5 mg  RFRP3/boar).
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Fig. 4. Least squares means (±SEM) for plasma concentrations of growth
hormone during the pre-treatment (minute 0–75), treatment (minute
75–180) and post-treatment (minute 180–285) periods. Boars were
treated with either saline (n = 4; no fill) or 8.5 mg  RFRP3 (n = 5; solid
fill) during the treatment period. Treatment × Period, P < 0.01. a,b,cWithin
treatment, means are different (P < 0.05).
4. Discussion
This is the first investigation into the effects of RFRP3
on in vivo secretion of LH and GH in boars. Chinese Meis-
han boars have greater concentrations of LH and gonadal
steroids than cross-bred boars of European breeds (Wise
et al., 1996; Zanella et al., 1996). It was thus reasoned
that the greater LH concentration of Meishan boars made
them a more desirable choice than white composite boars
to evaluate the potential inhibition of RFRP3 on LH in
male pigs. The suppressive effects of peripheral infusion
of RFRP3 on secretion of LH in these boars were slight and
inconsistent between animals. A role of RFRP3 in regula-
tion of the growth axis of the boar appears possible. These
results further classify the functional role of RFRP3 outside
of the reproductive axis and demonstrate the variation in
function of this peptide across mammalian species.
Present results indicate that RFRP3, when administered
intravenously, can act to suppress mean concentrations of
LH in mature boars. Kadokawa et al. (2009) and Caraty
et al. (2012) employing a similar approach observed that
repeated intravenous infusion of RFRP3 did not reduce
mean concentration of LH in gonadectomized male cattle or
ovariectomized ewes, respectively. Additionally, repeated
peripheral infusion of RFRP3 failed to suppress LH secretion
in cyclic mares during the breeding season (Thorson et al.,
2014). In rodents, RFRP3 suppressed (Johnson et al., 2007;
Pineda et al., 2010a), had no effect (Anderson et al., 2009;
Murakami et al., 2008), or increased (Ancel et al., 2012)
in vivo secretion of LH. There are similar conflicting reports
on the in vivo effects of RFRP3 on LH secretion in sheep
(Caraty et al., 2012; Clarke et al., 2008). These inconsistent
results have lead to controversy about the functional role
of RFRP3 as a hypophysiotropic hormone in mammals.
In estrous cyclic mares (Thorson et al., 2014) and
ovariectomized ewes (Caraty et al., 2012), RFRP3 did not
affect variables of LH pulses. Kadokawa et al. (2009)
observed that intravenous infusion of RFRP3 suppressed
frequency of LH pulses but did not affect LH pulse ampli-
tude in gonadectomized male cattle. Conversely, RFRP3
suppressed LH pulse amplitude but not LH pulse frequency
in ovariectomized ewes (Clarke et al., 2008). When individ-
ual LH profiles were examined, LH secretion in some but
not all boars appeared to be suppressed during the RFRP3
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treatment period. Other boars appeared to have a latent
response to the suppressive effects of RFRP3. The later
response is difficult to explain given the relatively short
half-life of RFRP3 in general circulation (Caraty et al., 2012;
Pineda et al., 2010b; Smith et al., 2012). The modest effect
of RFRP3 to suppress LH pulses in steers and ewes stopped
immediately upon cessation of repeated RFRP3 injection. In
ewes, nerve terminals containing RFRP3 are located in the
external zone of the median eminence (Clarke et al., 2008)
suggesting a pituitary site of action. In accordance with this
finding, it has been reported that RFRP3 is secreted in a pul-
satile fashion into the hypophyseal portal circulation of the
mature ovary-intact ewe (Smith et al., 2012). These previ-
ous data, together with the recent observation that RFRP3
suppressed GnRH-induced secretion of LH from primary
cultures of anterior pituitary cells of gilts (Li et al., 2013),
are strong justification for the approach utilized in the cur-
rent study in which a large loading dose was followed by
repeated injection every 15 min  into the peripheral circu-
lation.
With the present inconsistency in understanding of the
role of RFRP3 in regulating LH secretion in mammals, it
remains unclear where the site of RFRP3 action lies. Based
on reports that RFRP3 inhibited GnRH-induced secretion of
LH from primary cultures of anterior pituitary cells (Clarke
et al., 2008; Kadokawa et al., 2009; Li et al., 2013), in the
present study RFRP3 was administered into the periph-
eral circulation of boars. However, RFRP3 immunoreactive
nerve terminals have been observed in close proximity to
GnRH cell bodies in rats (Kriegsfeld et al., 2006) and sheep
(Smith et al., 2008); and RFRP3 was found to stimulate
GnRH neurons, as measured by expression of c-Fos, in rats
(Ancel et al., 2012). Moreover, RFRP3 reduced the firing
rate of GnRH neurons in sections of mouse brain in culture
(Ducret et al., 2009). The putative RFRP3 receptor, GPR147,
was found in the hypothalamus of the gilt and RFRP3 sup-
pressed secretion of GnRH from cultured hypothalamic
explants obtained from gilts (Li et al., 2012, 2013). Whether
RFRP3 functions centrally to inhibit the secretion of LH in
the pig requires further investigation.
It should be noted that the dose of RFRP3 used in
the present study was greater than that in our prelimi-
nary study (Heidorn et al., 2010) in which doses of RFRP3
that were comparable to those reported to suppress LH
pulses in sheep (Clarke et al., 2008) or steers (Kadokawa
et al., 2009) were ineffective at suppressing LH secre-
tion in ovariectomized prepubertal gilts. As previously
described, the inhibitory effects of RFRP3 on LH secretion
are inconsistent; even when used at similar doses in the
same species. As discussed by Thorson et al. (2014), the
lack of biological activity between different preparations
of RFRP3 seems an implausible explanation for the incon-
sistent results reported for RFRP3 in the literature. The
last four C-terminal amino acids and amidation signal are
required for binding and activation of GPR147 (Findeisen
et al., 2011; Yoshida et al., 2003) and these are well con-
served among species, including the pig (Li et al., 2012).
Expression of the GPR147 gene in the hypothalamus and
adenohypophysis of pigs was observed to fluctuate with
stage of the estrous cycle (Li et al., 2012); thus, subtle differ-
ences in the amount of GPR147 available for binding RFRP3
likely represent a more reasonable explanation for these
discrepancies, and may  explain the individual response to
RFRP3 observed in the current study.
The RFRP3 neuropeptide is not solely selective to
the reproductive axis. There was  no difference in mean
circulating concentrations of GH between saline-treated
and RFRP3-treated boars during the treatment period;
however, examination of individual secretory patterns
indicates that GH was suppressed during the early treat-
ment period in RFRP3-treated boars (see Fig. 3). After RFRP3
treatment ceased, GH secretion was restored. As a conse-
quence, mean concentrations of GH in RFRP3-treated boars
were greater in the post-treatment period. In contrast to
the present results in the boar, circulating concentrations
of GH rapidly increased following intracerebroventricu-
lar infusion of RFRP3 in prepubertal (Johnson and Fraley,
2008) and mature (Johnson et al., 2007) intact, male rats.
The stimulatory effect of RFRP3 on GH secretion in the
rat was evident at lesser doses, but not at greater doses
(Johnson et al., 2007). The decreased GH secretion may
be attributable to the relatively large dose of RFRP3 used
in boars in the present study. Central infusion of RFRP3
increased GHRH mRNA in accordance with the subsequent
increase in plasma concentrations of GH (Johnson and
Fraley, 2008) indicating that the site of GH regulation in
rats lies within the hypothalamus. Whether RFRP3 may
function through its receptor in the hypothalamus (Li et al.,
2012) to regulate GHRH neuronal function within the arcu-
ate and ventromedial nuclei of boars (Leshin et al., 1994)
remains to be elucidated.
In conclusion, the present study represents the first
investigation into the effects of RFRP3 on in vivo secretion
of LH and GH in the boar. It was recently reported that
RFRP3 inhibited GnRH-induced secretion of LH from pri-
mary cultures of porcine anterior pituitary cells collected
from gilts (Li et al., 2013). The current results indicate that
RFRP3 can suppress mean concentrations of LH in sexu-
ally mature boars. The secretory response of LH to RFRP3
was  minimal and varied between animals, which does not
strongly support the idea that RFRP3 is a potent hypophys-
iotropic hormone in the pig. The role of RFRP3 in regulating
the gonadotropic axis of mammals remains controversial
due to inconsistent results reported in the literature for a
number of species. The current data, unfortunately, do not
clarify the role of RFRP3 in regulating in vivo secretion of
LH in the pig; however, alterations in secretion of GH may
suggest a functional role of RFRP3 in the neuroendocrine
growth axis of male pigs. Further study into these mecha-
nisms is required to understand the role that RFRP3 plays
in regulating swine physiology.
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